ClinicalTrials.gg
Sign In

Hallucinations clinical trials

The registry lists 136 studies for Hallucinations across more than 10 countries. 35 are recruiting or about to start. 48 of them are mainly about Hallucinations (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Hallucinations studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
73
Recruiting
23
Status unknown
14
Terminated
12
Not yet recruiting
10
Enrolling by invitation
2

Phase

Phase 2
20
Phase 3
8
Phase 1
4
Early Phase 1
3
Phase 4
3

Where

United States
51
France
25
Germany
9
Netherlands
7
Switzerland
7
Canada
7

Who runs them

Yale University (8) · ACADIA Pharmaceuticals Inc. (5) · Hôpital le Vinatier (4) · Ciusss de L'Est de l'Île de Montréal (4) · University Hospital, Caen (3) · Columbia University (3) · University of North Carolina, Chapel Hill (3) · Psychiatric University Hospital, Zurich (2)

What is being tested here

Drugs under test in Hallucinations studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Remlifanserin222
ML-007C202
Pimavanserin115
LY03017102
Quetiapine101
Nelotanserin002
Lithium001
Morphine011
Ketamine011
Aqw-051001

Drug classes tested here Antipsychotics 1 open

Coming up

2phase 3 studies under way
6studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 6

Who these studies take

Of the 23 Hallucinations studies recruiting now, 8 (35%) set no upper age limit and 11 (48%) stop at 75 or younger. 3 (13%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (9%) take healthy volunteers.

Recruiting studies that take each age, of 23
AgeWomenMen
101 (4%)1 (4%)
1821 (91%)21 (91%)
3021 (91%)21 (91%)
4021 (91%)21 (91%)
5020 (87%)20 (87%)
6517 (74%)17 (74%)
7512 (52%)12 (52%)
8512 (52%)12 (52%)

Across all 136 studies, recruiting or not: 61% stop at 75 or younger and 55% at 65; 14% take children; 0% are for women only and 1% for men only; 17% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hallucinations studies take

Of 53 interventional studies with no phase under Hallucinations, half reached primary completion within 37 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase37 mo20–56 · 53 studies—37 mo20–56 · 53 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 136. Browse all 136 → or search them.